Nuvaira raises $79m financing to pursue COPD treatment

Image: Targeted Lung Denervation (TLD) is currently under clinical investigation for chronic obstructive pulmonary diseaseand asthmaand is not yet commercially available. Photo: Courtesy of Nuvaira Inc.